Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L McGovern

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Cancers|June 19, 2024
Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-A Population-Based Observational StudyChenyang Wang, Michael K Rooney, Christopher Alvarez-Breckenridge, et al.
Neuro-Oncology Advances|September 21, 2022
Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysisRituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, et al.
International Journal of Radiation Oncology, Biology, Physics|April 19, 2024
Salvage Stereotactic Radiosurgery for Recurrent WHO Grade 2 and 3 Meningiomas: A Multicenter Study (STORM)Matthew Gallitto, Geoffrey Sedor, Albert Lee, et al.
Neuro-Oncology Advances|August 2, 2021
Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessmentKarine A Al Feghali, James W Randall, Diane D Liu, et al.
Journal for Immunotherapy of Cancer|July 4, 2023
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trialMehmet Altan, Yan Wang, Juhee Song, et al.
Science (New York, N.Y.)|July 30, 2021
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2Tia A Tummino, Veronica V Rezelj, Benoit Fischer, et al.
Neuro-Oncology Advances|April 28, 2023
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experienceTimothy A Gregory, Maximilian Mastall, Heather Lin, et al.
Neuro-Oncology Advances|August 11, 2021
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experienceNazanin K Majd, Maximilan Mastall, Heather Lin, et al.
Nature Genetics|March 9, 2023
Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infectionJin Wei, Ajinkya Patil, Clayton K Collings, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitorEd J Griffen, Daren Fearon, Briana L McGovern, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Cancers|June 19, 2024
Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-A Population-Based Observational StudyChenyang Wang, Michael K Rooney, Christopher Alvarez-Breckenridge, et al.
Neuro-Oncology Advances|September 21, 2022
Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysisRituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, et al.
International Journal of Radiation Oncology, Biology, Physics|April 19, 2024
Salvage Stereotactic Radiosurgery for Recurrent WHO Grade 2 and 3 Meningiomas: A Multicenter Study (STORM)Matthew Gallitto, Geoffrey Sedor, Albert Lee, et al.
Neuro-Oncology Advances|August 2, 2021
Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessmentKarine A Al Feghali, James W Randall, Diane D Liu, et al.
Journal for Immunotherapy of Cancer|July 4, 2023
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trialMehmet Altan, Yan Wang, Juhee Song, et al.
Science (New York, N.Y.)|July 30, 2021
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2Tia A Tummino, Veronica V Rezelj, Benoit Fischer, et al.
Neuro-Oncology Advances|April 28, 2023
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experienceTimothy A Gregory, Maximilian Mastall, Heather Lin, et al.
Neuro-Oncology Advances|August 11, 2021
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experienceNazanin K Majd, Maximilan Mastall, Heather Lin, et al.
Nature Genetics|March 9, 2023
Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infectionJin Wei, Ajinkya Patil, Clayton K Collings, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitorEd J Griffen, Daren Fearon, Briana L McGovern, et al.
Pageof 17